Abnormal Metabolism in the Progression of Nonalcoholic Fatty Liver Disease to Hepatocellular Carcinoma: Mechanistic Insights to Chemoprevention.

Orabi, Danny; Berger, Nathan A; Brown, J Mark.

Afiliação

Orabi D; Department of Cardiovascular and Metabolic Sciences, Lerner Research Institute of the Cleveland Clinic, Cleveland, OH 44106, USA.
Berger NA; Center for Microbiome and Human Health, Lerner Research Institute of the Cleveland Clinic, Cleveland, OH 44106, USA.
Brown JM; Department of Molecular Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH 44195, USA.

Cancers (Basel) ; 13(14)2021 Jul 11.

Article em En | MEDLINE | ID: mdl-34298687